![Emmett Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emmett Cunningham
Keine laufenden Positionen mehr
Profil
Emmett T.
Cunningham founded Ophthalmology Innovation Summit in 2009, Placid0, Inc. in 2020, and Eyconis, Inc. in 2024, where he is working as Chairman from 2024.
Dr. Cunningham also founded Pr3vent, Inc and Visara, Inc., where he is working as Executive Chairman.
Dr. Cunningham also currently works at California Pacific Medical Center, as Director-Uveitis Service, SFJ Pharmaceuticals, Inc., as Director, Lumos Pharma Sub, Inc., as Director, and various other companies.
Dr. Cunningham also formerly worked at NovaBridge Biosciences, as Vice Chairman in 2026, NewLink Genetics Corp., as Director, Restoration Robotics, Inc., as Independent Director from 2011 to 2018, and various other companies.
Dr. Cunningham received his graduate degree in 1991 and doctorate degree in 1990 from The Johns Hopkins University, undergraduate degree in 1981 from Drexel University, and doctorate degree in 1989 from the University of California San Diego.
Aktive Positionen von Emmett Cunningham
| Unternehmen | Position | Beginn |
|---|---|---|
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Direktor/Vorstandsmitglied | - |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Direktor/Vorstandsmitglied | - |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Direktor/Vorstandsmitglied | - |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services Operates medical centers | Corporate Officer/Principal | - |
Francis I Proctor Foundation | Corporate Officer/Principal | - |
UCSF School of Medicine
 UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.07.2008 |
Silk Technologies Ltd.
 Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops silk-derived protein (SDP) products for ophthalmic applications | Direktor/Vorstandsmitglied | - |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Private Equity Investor | 01.07.2023 |
Ehemalige bekannte Positionen von Emmett Cunningham
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Emmett Cunningham
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
32
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 32 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Restoration Robotics, Inc.
 Restoration Robotics, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hair transplantation | Health Technology |
Annexon, Inc.
 Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | Health Technology |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | Health Technology |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services Operates medical centers | Commercial Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides alternative asset management services | Finance |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Health Technology |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Finance |
UCSF School of Medicine
UCSF School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Develops non-surgical treatments for eye diseases | Health Technology |
Nacuity Pharmaceuticals, Inc.
 Nacuity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Silk Technologies Ltd.
Silk Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops silk-derived protein (SDP) products for ophthalmic applications | Health Technology |
Ophthalmology Innovation Summit
 Ophthalmology Innovation Summit Financial ConglomeratesFinance Provides investment services | Finance |
Pr3vent, Inc
 Pr3vent, Inc Medical/Nursing ServicesHealth Services Provides healthcare technology services | Health Services |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Investment ManagersFinance Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | Finance |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Aviceda Therapeutics, Inc.
 Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
Francis I Proctor Foundation | |
Placid0, Inc.
 Placid0, Inc. Packaged SoftwareTechnology Services Develops mobile platform for assessing ocular conditions | Technology Services |
Wählen Sie MarketScreener 
